| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.007 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |